This CX Programme is subject to change.


Search for words

Peripheral Proximal Arterial Ischaemia Challenges - Tuesday, 16th April
Venue:   Upper Main Auditorium
Time: 08:00 - 18:00
Imaging
Chairing:   Robert Morgan, President CIRSE, London, United Kingdom
Moderator:   Andrew Holden, Auckland, New Zealand
Paclitaxel: The last word
Chairing:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
Thomas Zeller, Bad Krozingen, Germany
Review of paclitaxel usage: The way forward
Chairing:   Roger Greenhalgh, London, United Kingdom
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
Thomas Zeller, Bad Krozingen, Germany
16:00 - 16:30
Edited case: Treating iliac occlusive disease with a covered endoprosthesis - Tuesday, 16th April
Case presenter:   Andrew Holden, Auckland, New Zealand
17:45 - 17:50
CX Debate: In the absence of suitable venous graft material prosthetic bypass is the answer - Tuesday, 16th April
Against the motion
17:45 - 17:50
Andrew Holden, Auckland, New Zealand

Peripheral Critical Ischaemia Challenges - Thursday, 18th April
Venue:   Lower Main Auditorium
Time: 08:00 - 18:00
10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
Thoracic Aortic Challenges - Thursday, 18th April
Venue:   Upper Main Auditorium
Time: 08:00 - 18:00
 
Radiation
Chairing:   Dittmar Böckler, President DGG, Heidelberg, Germany
Moderator:   Andrew Holden, Auckland, New Zealand
CX Vascular Access Masterclass - Wednesday, 17th April
Venue:   Pillar Hall Learning Centre
Time: 08:00 - 17:42
14:49 - 14:57
IN.PACT AV: Baseline data from the full cohort - Wednesday, 17th April
Speaker:   Andrew Holden, Auckland, New Zealand
14:57 - 15:17
DCBs: Is the data on PVD applicable to vascular access? - Wednesday, 17th April
Panel:   Andrew Holden, Auckland, New Zealand
CX Innovation Showcase - Thursday, 18th April
Venue:   Pillar Hall Learning Centre
Time: 07:30 - 18:00
09:40 - 09:50
Temporary drug-coated Spur system to address the challenges of DCB technology - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
 
Diagnostic and imaging innovation - Thursday, 18th April
Time: 16:00 - 16:40
Chairing:   Andrew Holden, Auckland, New Zealand
Moderator:   Stephen Greenhalgh, London, United Kingdom
Dragons' Den - Thursday, 18th April
Time: 16:55 - 18:05
Panel:   Andrew Holden, Auckland, New Zealand
Bob Mitchell, Irvine, United States
Peter Phillips, Didcot, United Kingdom
Chas Taylor, Horsham, United Kingdom
Jeffrey Jump, Mont-sur-Rolle, Switzerland
Alan Edwards, Ruthin, United Kingdom
Frans Moll, Utrecht, Netherlands
CX Peripheral Techniques & Technologies (live & edited cases) - Wednesday, 17th April
Venue:   Lower Main Auditorium
Time: 09:30 - 18:00
10:17 - 10:24
Optimised treatment strategies for post-PTA dissection - Wednesday, 17th April
Speaker:   Andrew Holden, Auckland, New Zealand
11:00 - 11:30
Edited case: Drug-coated balloon in AV access - Wednesday, 17th April
Speaker:   Andrew Holden, Auckland, New Zealand
Peripheral Arterial Podium 1st Session - Thursday, 18th April
Venue:   Lower Main Auditorium
Time: 10:30 - 12:30
10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms - Thursday, 18th April
Speaker:   Andrew Holden, Auckland, New Zealand
Pavilion activities - Endologix - Wednesday, 17th April
Venue:   Pillar Hall Learning Centre
Time: 17:45 - 19:30
18:15 - 19:30
Panel discussion - Wednesday, 17th April
Honourees:   Andrew Holden, Auckland, New Zealand